446:
1676:
921:
66:
344:
237:
123:
25:
329:
518:
replacement products designed to help smokers quit by replacing the nicotine supplied by cigarettes with a lower, steadier level in order to relieve withdrawal. This is to help users wean off nicotine gradually. Nicotine replacement therapy products (e.g. chewing gum, lozenges, transdermal systems)
519:
are indicated as temporary aids for cigarette smokers who want to give up smoking. They serve as alternative sources of nicotine and provide relief of nicotine withdrawal symptoms in nicotine-dependent individuals who are acutely withdrawing from cigarette smoking.
535:
in 1991, one of the earliest products brought to market to provide an alternative to the withdrawal symptoms of quitting smoking. Nicotine gums were already widely used among consumers.
133:
247:
1613:
1081:
1606:
147:
of the topic and provide significant coverage of it beyond a mere trivial mention. If notability cannot be shown, the article is likely to be
686:
638:
1223:
996:
82:
1620:
498:
480:
427:
218:
104:
52:
75:
465:
Please help improve this article by looking for better, more reliable sources. Unreliable citations may be challenged and removed.
1627:
718:
144:
1644:
1553:
753:
1599:
365:
961:
616:
459:
140:
532:
671:
573:
408:
308:
255:
199:
156:
1141:
559:
454:
380:
280:
171:
1702:
542:
in the US, Nicabate in
Australia and New Zealand and NiQuitin CQ in China, many parts of Europe and South America.
354:
266:
251:
1318:
361:
38:
387:
287:
178:
1655:
1548:
1322:
1205:
1091:
991:
881:
1101:
1086:
1707:
1372:
1161:
1131:
805:
771:
711:
445:
394:
294:
185:
1649:
1076:
810:
152:
1001:
376:
276:
167:
148:
1046:
642:
1405:
954:
1679:
1504:
1392:
794:
1532:
1494:
1489:
1156:
1011:
924:
845:
704:
1568:
1514:
1479:
1313:
830:
81:
It may require cleanup to comply with
Knowledge (XXG)'s content policies, particularly
401:
301:
192:
1696:
1563:
1484:
1151:
1146:
1051:
855:
86:
44:
1573:
1558:
1509:
1278:
947:
825:
815:
624:
1522:
1499:
1171:
835:
343:
1578:
1527:
1435:
1387:
1201:
1191:
1186:
1176:
1056:
865:
840:
789:
1661:
1445:
1425:
1382:
1377:
1357:
1352:
1293:
1263:
1243:
1196:
1181:
1166:
850:
820:
784:
776:
748:
577:
1420:
1415:
1410:
1367:
1303:
1298:
1273:
1253:
1238:
1233:
1136:
766:
666:
539:
515:
1400:
1362:
1344:
1308:
1268:
1248:
1228:
1096:
1071:
1066:
1061:
970:
901:
761:
743:
528:
265:
if you can. Unsourced or poorly sourced material may be challenged and
1440:
1288:
1283:
1258:
1026:
1006:
906:
727:
538:
The product is sold globally under different brand names such as
139:
Please help to demonstrate the notability of the topic by citing
1450:
860:
943:
700:
681:
439:
337:
230:
116:
59:
18:
676:
598:
696:
262:
939:
574:"About Nicoderm CQ & Nicotine Replacement Therapy"
74:
A major contributor to this article appears to have a
691:
1637:
1591:
1541:
1470:
1463:
1337:
1216:
1124:
1117:
1110:
1037:
1021:
984:
977:
894:
874:
736:
368:. Unsourced material may be challenged and removed.
1614:GlaxoSmithKline Services Unlimited v Commission
134:notability guidelines for products and services
261:Please review the contents of the article and
955:
712:
617:"10/28/96 READY TO TOSS THOSE CANCER STICKS?"
8:
53:Learn how and when to remove these messages
1467:
1121:
1114:
981:
962:
948:
940:
719:
705:
697:
499:Learn how and when to remove this message
481:Learn how and when to remove this message
428:Learn how and when to remove this message
219:Learn how and when to remove this message
105:Learn how and when to remove this message
1607:Christopher v. SmithKline Beecham Corp.
551:
16:Range of nicotine replacement products
1082:Recherche et Industrie Thérapeutiques
7:
366:adding citations to reliable sources
997:GlaxoSmithKline Pharmaceuticals Ltd
14:
1621:United States v. Glaxo Group Ltd.
34:This article has multiple issues.
1675:
1674:
1628:United States v. GlaxoSmithKline
920:
919:
444:
342:
327:
235:
121:
85:. Please discuss further on the
64:
23:
1645:Drug Industry Documents Archive
531:, NiQuitin was approved by the
353:needs additional citations for
132:may not meet Knowledge (XXG)'s
42:or discuss these issues on the
1600:Canada v. GlaxoSmithKline Inc.
263:add the appropriate references
1:
639:"GlaxoSmithKline: NiQuitin"
248:reliable medical references
1724:
141:reliable secondary sources
130:The topic of this article
1670:
1102:Smith, Kline & French
915:
254:or relies too heavily on
1092:S. E. Massengill Company
992:GlaxoSmithKline Pakistan
1087:Reliant Pharmaceuticals
687:GSK Product Information
453:Some of this article's
1650:GlaxoSmithKline Prize
1077:Human Genome Sciences
83:neutral point of view
1047:Allen & Hanburys
1002:Stiefel Laboratories
887:Brian McNamara (CEO)
621:www.businessweek.com
560:"Wiley Interscience"
362:improve this article
1554:Silas M. Burroughs
1097:SmithKline Beecham
1062:Burroughs Wellcome
136:
1703:Smoking cessation
1690:
1689:
1587:
1586:
1459:
1458:
1333:
1332:
1033:
1032:
937:
936:
509:
508:
501:
491:
490:
483:
438:
437:
430:
412:
336:
335:
312:
229:
228:
221:
203:
131:
115:
114:
107:
78:with its subject.
57:
1715:
1678:
1677:
1505:Patrick Vallance
1468:
1197:Wellbutrin/Zyban
1122:
1115:
982:
964:
957:
950:
941:
929:
923:
922:
730:
721:
714:
707:
698:
654:
653:
651:
650:
641:. Archived from
635:
629:
628:
623:. Archived from
613:
607:
606:
595:
589:
588:
586:
585:
576:. Archived from
570:
564:
563:
556:
504:
497:
486:
479:
475:
472:
466:
448:
440:
433:
426:
422:
419:
413:
411:
370:
346:
338:
331:
330:
322:
319:
313:
311:
270:
239:
238:
231:
224:
217:
213:
210:
204:
202:
161:
125:
124:
117:
110:
103:
99:
96:
90:
76:close connection
68:
67:
60:
49:
27:
26:
19:
1723:
1722:
1718:
1717:
1716:
1714:
1713:
1712:
1693:
1692:
1691:
1686:
1666:
1633:
1583:
1537:
1533:Laurie Glimcher
1500:Manvinder Banga
1495:Roy M. Anderson
1490:Simon Dingemans
1472:
1455:
1329:
1212:
1106:
1039:
1029:
1017:
1012:ViiV Healthcare
973:
968:
938:
933:
925:
911:
890:
870:
732:
728:
725:
663:
658:
657:
648:
646:
637:
636:
632:
615:
614:
610:
597:
596:
592:
583:
581:
572:
571:
567:
558:
557:
553:
548:
529:GlaxoSmithKline
525:
505:
494:
493:
492:
487:
476:
470:
467:
464:
449:
434:
423:
417:
414:
371:
369:
359:
347:
332:
328:
323:
317:
314:
271:
260:
256:primary sources
240:
236:
225:
214:
208:
205:
162:
160:
138:
126:
122:
111:
100:
94:
91:
80:
69:
65:
28:
24:
17:
12:
11:
5:
1721:
1719:
1711:
1710:
1705:
1695:
1694:
1688:
1687:
1685:
1684:
1671:
1668:
1667:
1665:
1664:
1659:
1652:
1647:
1641:
1639:
1635:
1634:
1632:
1631:
1624:
1617:
1610:
1603:
1595:
1593:
1589:
1588:
1585:
1584:
1582:
1581:
1576:
1571:
1569:Henry Wellcome
1566:
1561:
1556:
1551:
1549:Thomas Beecham
1545:
1543:
1539:
1538:
1536:
1535:
1530:
1525:
1520:
1517:
1515:Lynn Elsenhans
1512:
1507:
1502:
1497:
1492:
1487:
1482:
1480:Philip Hampton
1476:
1474:
1465:
1461:
1460:
1457:
1456:
1454:
1453:
1448:
1443:
1438:
1433:
1428:
1423:
1418:
1413:
1408:
1406:Goody's Powder
1403:
1398:
1395:
1390:
1385:
1380:
1375:
1370:
1365:
1360:
1355:
1350:
1347:
1341:
1339:
1335:
1334:
1331:
1330:
1328:
1327:
1316:
1311:
1306:
1301:
1296:
1291:
1286:
1281:
1276:
1271:
1266:
1261:
1256:
1251:
1246:
1241:
1236:
1231:
1226:
1220:
1218:
1214:
1213:
1211:
1210:
1199:
1194:
1189:
1184:
1179:
1174:
1169:
1164:
1159:
1154:
1149:
1144:
1139:
1134:
1128:
1126:
1119:
1112:
1108:
1107:
1105:
1104:
1099:
1094:
1089:
1084:
1079:
1074:
1072:Glaxo Wellcome
1069:
1064:
1059:
1054:
1049:
1043:
1041:
1035:
1034:
1031:
1030:
1025:
1023:
1019:
1018:
1016:
1015:
1009:
1004:
999:
994:
988:
986:
979:
975:
974:
969:
967:
966:
959:
952:
944:
935:
934:
932:
931:
916:
913:
912:
910:
909:
904:
898:
896:
892:
891:
889:
888:
885:
878:
876:
872:
871:
869:
868:
863:
858:
853:
848:
843:
838:
833:
828:
823:
818:
813:
808:
803:
800:
797:
792:
787:
782:
779:
774:
769:
764:
759:
756:
751:
746:
740:
738:
734:
733:
726:
724:
723:
716:
709:
701:
695:
694:
689:
684:
679:
674:
669:
662:
661:External links
659:
656:
655:
630:
627:on 2000-01-23.
608:
590:
565:
550:
549:
547:
544:
524:
521:
514:is a range of
507:
506:
489:
488:
471:September 2024
455:listed sources
452:
450:
443:
436:
435:
350:
348:
341:
334:
333:
326:
324:
243:
241:
234:
227:
226:
209:September 2024
129:
127:
120:
113:
112:
72:
70:
63:
58:
32:
31:
29:
22:
15:
13:
10:
9:
6:
4:
3:
2:
1720:
1709:
1708:Haleon brands
1706:
1704:
1701:
1700:
1698:
1683:
1682:
1673:
1672:
1669:
1663:
1660:
1658:
1657:
1653:
1651:
1648:
1646:
1643:
1642:
1640:
1636:
1630:
1629:
1625:
1623:
1622:
1618:
1616:
1615:
1611:
1609:
1608:
1604:
1602:
1601:
1597:
1596:
1594:
1590:
1580:
1577:
1575:
1572:
1570:
1567:
1565:
1564:John K. Smith
1562:
1560:
1557:
1555:
1552:
1550:
1547:
1546:
1544:
1540:
1534:
1531:
1529:
1526:
1524:
1521:
1519:Jesse Goodman
1518:
1516:
1513:
1511:
1508:
1506:
1503:
1501:
1498:
1496:
1493:
1491:
1488:
1486:
1485:Emma Walmsley
1483:
1481:
1478:
1477:
1475:
1469:
1466:
1462:
1452:
1449:
1447:
1444:
1442:
1439:
1437:
1434:
1432:
1429:
1427:
1424:
1422:
1419:
1417:
1414:
1412:
1409:
1407:
1404:
1402:
1399:
1396:
1394:
1391:
1389:
1386:
1384:
1381:
1379:
1376:
1374:
1371:
1369:
1366:
1364:
1361:
1359:
1356:
1354:
1351:
1348:
1346:
1343:
1342:
1340:
1336:
1326:
1325:
1320:
1317:
1315:
1312:
1310:
1307:
1305:
1302:
1300:
1297:
1295:
1292:
1290:
1287:
1285:
1282:
1280:
1277:
1275:
1272:
1270:
1267:
1265:
1262:
1260:
1257:
1255:
1252:
1250:
1247:
1245:
1242:
1240:
1237:
1235:
1232:
1230:
1227:
1225:
1222:
1221:
1219:
1215:
1209:
1208:
1203:
1200:
1198:
1195:
1193:
1190:
1188:
1185:
1183:
1180:
1178:
1177:Paxil/Seroxat
1175:
1173:
1170:
1168:
1165:
1163:
1160:
1158:
1155:
1153:
1150:
1148:
1145:
1143:
1140:
1138:
1135:
1133:
1130:
1129:
1127:
1123:
1120:
1116:
1113:
1109:
1103:
1100:
1098:
1095:
1093:
1090:
1088:
1085:
1083:
1080:
1078:
1075:
1073:
1070:
1068:
1065:
1063:
1060:
1058:
1055:
1053:
1052:Beecham Group
1050:
1048:
1045:
1044:
1042:
1038:Predecessors,
1036:
1028:
1024:
1020:
1013:
1010:
1008:
1005:
1003:
1000:
998:
995:
993:
990:
989:
987:
983:
980:
976:
972:
965:
960:
958:
953:
951:
946:
945:
942:
930:
928:
918:
917:
914:
908:
905:
903:
900:
899:
897:
893:
886:
883:
880:
879:
877:
873:
867:
864:
862:
859:
857:
854:
852:
849:
847:
844:
842:
839:
837:
834:
832:
829:
827:
824:
822:
819:
817:
814:
812:
809:
807:
804:
801:
798:
796:
793:
791:
788:
786:
783:
780:
778:
775:
773:
770:
768:
765:
763:
760:
757:
755:
752:
750:
747:
745:
742:
741:
739:
735:
731:
722:
717:
715:
710:
708:
703:
702:
699:
693:
690:
688:
685:
683:
680:
678:
675:
673:
670:
668:
665:
664:
660:
645:on 2008-12-16
644:
640:
634:
631:
626:
622:
618:
612:
609:
604:
600:
594:
591:
580:on 2008-12-18
579:
575:
569:
566:
561:
555:
552:
545:
543:
541:
536:
534:
530:
522:
520:
517:
513:
503:
500:
485:
482:
474:
462:
461:
456:
451:
447:
442:
441:
432:
429:
421:
410:
407:
403:
400:
396:
393:
389:
386:
382:
379: –
378:
374:
373:Find sources:
367:
363:
357:
356:
351:This article
349:
345:
340:
339:
325:
321:
310:
307:
303:
300:
296:
293:
289:
286:
282:
279: –
278:
274:
273:Find sources:
268:
264:
258:
257:
253:
249:
244:This article
242:
233:
232:
223:
220:
212:
201:
198:
194:
191:
187:
184:
180:
177:
173:
170: –
169:
165:
164:Find sources:
158:
154:
150:
146:
142:
135:
128:
119:
118:
109:
106:
98:
88:
84:
79:
77:
71:
62:
61:
56:
54:
47:
46:
41:
40:
35:
30:
21:
20:
1680:
1656:Side Effects
1654:
1626:
1619:
1612:
1605:
1598:
1574:Andrew Witty
1559:Mahlon Kline
1510:Vivienne Cox
1430:
1323:
1279:H5N1 vaccine
1206:
1040:acquisitions
978:Subsidiaries
926:
647:. Retrieved
643:the original
633:
625:the original
620:
611:
602:
593:
582:. Retrieved
578:the original
568:
554:
537:
526:
511:
510:
495:
477:
468:
457:
424:
415:
405:
398:
391:
384:
372:
360:Please help
355:verification
352:
315:
305:
298:
291:
284:
272:
252:verification
245:
215:
206:
196:
189:
182:
175:
163:
101:
92:
73:
50:
43:
37:
36:Please help
33:
1523:Judy Lewent
672:Nicoderm CQ
527:Created by
458:may not be
418:August 2024
318:August 2024
246:needs more
145:independent
1697:Categories
1592:Litigation
1579:Chris Gent
1528:Urs Rohner
1436:Parodontax
1244:Engerix-B
1057:Block Drug
884:(Chairman)
882:Dave Lewis
841:Parodontax
826:Nicotinell
649:2008-12-16
599:"PharmGKB"
584:2008-12-16
546:References
388:newspapers
377:"Niquitin"
288:newspapers
277:"Niquitin"
179:newspapers
168:"Niquitin"
153:redirected
39:improve it
1662:Study 329
1473:Directors
1471:Board of
1446:Sensodyne
1426:Nicorette
1383:Emergen-C
1378:ChapStick
1358:BC Powder
1353:Aquafresh
1294:Pandemrix
1264:Hepatyrix
1162:Flixonase
1142:Augmentin
851:Sensodyne
821:Nicorette
785:Emergen-C
777:ChapStick
758:Aquafresh
143:that are
95:June 2010
87:talk page
45:talk page
1681:Category
1431:NiQuitin
1421:Nicoderm
1416:Lucozade
1411:Horlicks
1393:Excedrin
1368:Caltrate
1314:Shingrix
1304:Rabavert
1299:Pediarix
1274:Infanrix
1254:FluLaval
1239:Cervarix
1234:Boostrix
1217:Vaccines
1192:Ventolin
1182:Serlipet
1172:Lamictal
1167:Hycamtin
1152:Beconase
1111:Products
927:Category
866:Voltaren
856:Theraflu
846:Polident
811:Macleans
802:Fenistil
795:Excedrin
767:Caltrate
754:Alinamin
682:Nicabate
677:Niquitin
667:Nicotine
603:PharmGKB
540:Nicoderm
516:nicotine
512:NiQuitin
460:reliable
1401:Geritol
1397:Flonase
1373:Centrum
1363:Biotene
1345:Actifed
1319:Twinrix
1309:Rotarix
1269:Hiberix
1249:Fluarix
1229:Bexsero
1187:Tagamet
1147:Avandia
1118:Current
985:Current
895:Related
836:Panadol
831:Otrivin
806:Flonase
772:Centrum
762:Biotene
744:Actifed
692:Whyquit
523:History
402:scholar
302:scholar
267:removed
193:scholar
157:deleted
1464:People
1441:Ribena
1338:Former
1289:Menveo
1284:Kinrix
1259:Havrix
1224:Arexvy
1202:Zantac
1157:Boniva
1132:Advair
1125:Pharma
1027:Haleon
1022:Former
1007:Tesaro
907:Pfizer
875:People
816:Nexium
799:Fenbid
781:Contac
737:Brands
729:Haleon
404:
397:
390:
383:
375:
304:
297:
290:
283:
275:
195:
188:
181:
174:
166:
149:merged
1638:Other
1542:Other
1349:Advil
1067:Glaxo
1014:(85%)
749:Advil
409:JSTOR
395:books
309:JSTOR
295:books
200:JSTOR
186:books
155:, or
1451:Tums
1324:more
1207:more
1137:Alli
861:Tums
381:news
281:news
250:for
172:news
1388:Eno
971:GSK
902:GSK
790:Eno
533:FDA
364:by
1699::
1321:…
1204:…
619:.
601:.
269:.
151:,
48:.
963:e
956:t
949:v
720:e
713:t
706:v
652:.
605:.
587:.
562:.
502:)
496:(
484:)
478:(
473:)
469:(
463:.
431:)
425:(
420:)
416:(
406:·
399:·
392:·
385:·
358:.
320:)
316:(
306:·
299:·
292:·
285:·
259:.
222:)
216:(
211:)
207:(
197:·
190:·
183:·
176:·
159:.
137:.
108:)
102:(
97:)
93:(
89:.
55:)
51:(
Text is available under the Creative Commons Attribution-ShareAlike License. Additional terms may apply.